Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:
   

Recent Articles

China Medical In-licenses China Rights to Novel Anemia Drug from Zydus Cadila
Oncologie Collaborates with Genialis to Identify Patients for Clinical Trials
Celltrion Plans $513 Million Wuhan Biologics Facility; 18 Biologic Launches in China by 2030
TenNor Receives Orphan Drug Designation in the US for Biofilm Infection Candidate
Week in Review: China's I-Mab Stages $104 Million NASDAQ IPO
ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes


Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China